Nettacin (Netilmicin)

Netilmicin is used to manage bacterial ocular infections by targeting susceptible Gram‑negative and Gram‑positive organisms.

• Bacterial conjunctivitis: reduces bacterial load and accelerates resolution of redness and discharge.
• Keratitis: eradicates causative bacteria, promoting corneal healing.
• Other ocular bacterial infections: provides broad‑spectrum coverage for infections of the conjunctiva, cornea, and eyelid.

• Netilmicin binds to the bacterial 30S ribosomal subunit, causing misreading of mRNA and inhibition of protein synthesis. This disruption leads to bacterial cell death, providing a bactericidal effect against susceptible ocular pathogens.

Topical netilmicin may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects

• Eye irritation: mild discomfort after instillation.
• Burning sensation: transient stinging on application.
• Redness: conjunctival hyperemia.
• Tearing: increased lacrimation.
• Blurred vision: temporary visual disturbance.
• Stinging: brief sharp sensation.

Serious or Rare Side Effects

• Allergic contact dermatitis: rash or swelling of the eyelid.
• Corneal ulceration: worsening of corneal lesions.
• Systemic ototoxicity: rare hearing impairment with extensive absorption.
• Nephrotoxicity: potential kidney effects if systemic exposure occurs.
• Severe hypersensitivity reactions: anaphylaxis or angioedema.

When prescribing Nettacin, clinicians should consider several safety precautions to minimize risks.

• Assess renal function: evaluate patient’s kidney status before and during therapy.
• Avoid in patients with known hypersensitivity to aminoglycosides: discontinue if reaction occurs.
• Confirm bacterial etiology: use only for confirmed or strongly suspected bacterial infections.
• Do not wear contact lenses: remove lenses during treatment to prevent drug absorption.
• Monitor for prolonged use: limit duration to reduce systemic absorption.
• Store at room temperature: keep in original container, protect from light and moisture.

Netilmicin can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid)

• Systemic aminoglycosides: concurrent use may increase risk of nephro‑ and ototoxicity.
• Neuromuscular blocking agents: may potentiate muscle weakness.

Moderate Interactions (Monitor Closely)

• Topical anesthetics: may enhance corneal toxicity when used together.
• Other ophthalmic antibiotics: may alter bacterial susceptibility patterns.
• Non‑steroidal anti‑inflammatory eye drops: monitor for additive irritation.